Beyond PARP Inhibitors in Advanced Breast Cancer Patients with Germline BRCA1/2 Mutations: Focus on CDK4/6-Inhibitors and Data Review on Other Biological TherapiesMarta Nerone, Rossella Graffeo|Cancers|2023Cited by 11
Biological Therapies Beyond PARP-Inhibitors in Advanced Breast Cancer Patients with Germline BRCA1/2 MutationsMarta Nerone, Rossella Graffeo|Preprints.org|2023Cited by 1